Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$72.75 - $90.6 $253,533 - $315,741
3,485 New
3,485 $288,000
Q4 2021

Feb 10, 2022

SELL
$49.55 - $74.59 $1.26 Million - $1.9 Million
-25,517 Closed
0 $0
Q3 2021

Oct 28, 2021

SELL
$57.6 - $70.59 $191,001 - $234,076
-3,316 Reduced 11.5%
25,517 $1.8 Million
Q2 2021

Aug 10, 2021

BUY
$51.81 - $118.56 $730,002 - $1.67 Million
14,090 Added 95.57%
28,833 $1.92 Million
Q1 2021

Jul 21, 2021

BUY
$111.01 - $139.48 $254,212 - $319,409
2,290 Added 18.39%
14,743 $1.64 Million
Q4 2020

Feb 12, 2021

SELL
$88.75 - $119.95 $1.6 Million - $2.16 Million
-18,033 Reduced 59.15%
12,453 $1.48 Million
Q3 2020

Oct 30, 2020

BUY
$75.65 - $93.58 $196,463 - $243,027
2,597 Added 9.31%
30,486 $2.66 Million
Q2 2020

Aug 05, 2020

SELL
$84.96 - $118.91 $286,060 - $400,369
-3,367 Reduced 10.77%
27,889 $2.5 Million
Q1 2020

May 11, 2020

BUY
$74.34 - $121.82 $735,371 - $1.21 Million
9,892 Added 46.3%
31,256 $3.12 Million
Q4 2019

Feb 13, 2020

SELL
$114.37 - $129.46 $1.07 Million - $1.21 Million
-9,352 Reduced 30.45%
21,364 $2.46 Million
Q3 2019

Nov 08, 2019

BUY
$117.16 - $138.52 $22,611 - $26,734
193 Added 0.63%
30,716 $3.88 Million
Q2 2019

Jul 08, 2019

BUY
$81.74 - $120.34 $2.49 Million - $3.67 Million
30,523 New
30,523 $3.67 Million
Q2 2018

Aug 20, 2018

SELL
$71.53 - $95.75 $598,777 - $801,523
-8,371 Closed
0 $0
Q1 2018

May 21, 2018

SELL
$60.72 - $74.41 $6.03 Million - $7.39 Million
-99,353 Reduced 92.23%
8,371 $0
Q4 2017

Feb 13, 2018

BUY
$44.96 - $58.99 $4.84 Million - $6.35 Million
107,724
107,724 $6.26 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.77B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Winton Group LTD Portfolio

Follow Winton Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.